NASDAQ:CLVR Clever Leaves (CLVR) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free CLVR Stock Alerts $3.87 -0.06 (-1.53%) (As of 05:12 PM ET) Add Compare Share Share Today's Range$3.85▼$3.8750-Day Range$3.31▼$5.3252-Week Range$1.72▼$9.60Volume4,121 shsAverage Volume21,122 shsMarket Capitalization$6.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Clever Leaves alerts: Email Address Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. About Clever Leaves Stock (NASDAQ:CLVR)Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.Read More CLVR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLVR Stock News HeadlinesApril 13, 2024 | morningstar.comClever Leaves Holdings Inc Ordinary Shares CLVRApril 3, 2024 | benzinga.comClever Leaves Holdings Stock (NASDAQ:CLVR), Earnings Estimates, EPS, and RevenueApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 2, 2024 | msn.comCannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense ReductionsApril 1, 2024 | globenewswire.comClever Leaves Reports Fourth Quarter and Full Year 2023 ResultsFebruary 13, 2024 | finance.yahoo.comClever Leaves and Paradise Seeds to Develop and Register Genetic Assets in ColombiaFebruary 11, 2024 | investing.comClever Leaves Holdings Inc (CLVRW)January 30, 2024 | investing.comClever Leaves Holdings Inc (CLVR)April 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.January 15, 2024 | benzinga.comClever Leaves Holdings Stock (NASDAQ:CLVR), Guidance and ForecastJanuary 15, 2024 | benzinga.comClever Leaves Holdings Stock (NASDAQ:CLVR) Dividends: History, Yield and DatesDecember 7, 2023 | tmcnet.comClever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of InvestorsDecember 5, 2023 | barrons.comCLVR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Clever Leaves Holdings Inc. (CLVR) Investors to Contact the Firm to Claim Your LossesDecember 1, 2023 | tmcnet.comRobbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of ShareholderNovember 28, 2023 | benzinga.comClever Leaves Holdings Inc. Investors Should Contact Robbins LLP for Information About Our Investigation of CLVRNovember 9, 2023 | msn.comClever Leaves GAAP EPS of -$4.60 misses by $2.50, revenue of $3.8M misses by $1.4MNovember 2, 2023 | finance.yahoo.comClever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ETSeptember 15, 2023 | seekingalpha.comClever Leaves regains compliance with Nasdaq's minimum bid price ruleSeptember 13, 2023 | finance.yahoo.comClever Leaves Regains Compliance with Nasdaq Minimum Bid Price RequirementAugust 31, 2023 | msn.comClever Leaves Holdings (CLVR) Price Target Increased by 2900.00% to 24.48August 30, 2023 | benzinga.comMeet The First Vertically Integrated Medicinal Cannabis Company Certified As Carbon-NeutralAugust 29, 2023 | finance.yahoo.comClever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis CompanyAugust 28, 2023 | benzinga.comClever Leaves Fights Back: Bold Moves Secure Its NASDAQ Position Amid Global Cannabis Market UncertaintiesAugust 24, 2023 | finance.yahoo.comClever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing RequirementsAugust 15, 2023 | finance.yahoo.comQ2 2023 Clever Leaves Holdings Inc Earnings CallAugust 15, 2023 | finance.yahoo.comClever Leaves Holdings Inc. (NASDAQ:CLVR) Q2 2023 Earnings Call TranscriptAugust 14, 2023 | benzinga.comClever Leaves Reports 21% Revenue Growth And 10% Gross Profit Rise In 2Q 2023See More Headlines Receive CLVR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clever Leaves and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/01/2024Today4/25/2024Next Earnings (Estimated)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:CLVR CUSIPN/A CIK1819615 Webwww.cleverleaves.com Phone561-634-7430FaxN/AEmployees296Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($11.3051) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,900,000.00 Net Margins-102.77% Pretax Margin-113.27% Return on Equity-63.32% Return on Assets-49.91% Debt Debt-to-Equity Ratio0.03 Current Ratio2.40 Quick Ratio1.63 Sales & Book Value Annual Sales$17.42 million Price / Sales0.39 Cash FlowN/A Price / Cash FlowN/A Book Value$14.02 per share Price / Book0.28Miscellaneous Outstanding Shares1,750,000Free Float1,611,000Market Cap$6.77 million OptionableNo Data Beta1.54 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Andres Fajardo (Age 46)Co-Founder, CEO & Director Comp: $232.02kMr. Henry R. Hague III (Age 52)Chief Financial Officer Comp: $311.02kMr. Julian Wilches (Age 45)Chief Regulatory Officer Comp: $202.49kMr. Gustavo EscobarChief Operating OfficerMs. Marta Pinto LeiteGeneral Counsel & Corporate SecretaryMr. Andrew MillerHead of Business DevelopmentMr. Camilo BohorquezHead of ColombiaMs. Caroline KliessManaging Director of GermanyJackie KeshnerInvestor Relations ExecutiveMore ExecutivesKey CompetitorsTrevenaNASDAQ:TRVNCan-Fite BioPharmaNYSE:CANFeFFECTOR TherapeuticsNASDAQ:EFTRProtagenic TherapeuticsNASDAQ:PTIXTenax TherapeuticsNASDAQ:TENXView All CompetitorsInsidersAndres FajardoSold 1,561 sharesTotal: $4,495.68 ($2.88/share)Julian WilchesSold 131 sharesTotal: $377.28 ($2.88/share)Andres FajardoSold 177 sharesTotal: $361.08 ($2.04/share)Julian WilchesSold 135 sharesTotal: $275.40 ($2.04/share)Andres FajardoSold 97 sharesTotal: $640.20 ($6.60/share)View All Insider Transactions CLVR Stock Analysis - Frequently Asked Questions How have CLVR shares performed in 2024? Clever Leaves' stock was trading at $2.09 at the beginning of the year. Since then, CLVR stock has increased by 85.2% and is now trading at $3.87. View the best growth stocks for 2024 here. Are investors shorting Clever Leaves? Clever Leaves saw a drop in short interest in April. As of April 15th, there was short interest totaling 10,600 shares, a drop of 47.3% from the March 31st total of 20,100 shares. Based on an average daily trading volume, of 18,900 shares, the short-interest ratio is currently 0.6 days. View Clever Leaves' Short Interest. When is Clever Leaves' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our CLVR earnings forecast. How were Clever Leaves' earnings last quarter? Clever Leaves Holdings Inc. (NASDAQ:CLVR) posted its quarterly earnings data on Monday, April, 1st. The company reported ($2.96) earnings per share (EPS) for the quarter. The business earned $4.64 million during the quarter. Clever Leaves had a negative net margin of 102.77% and a negative trailing twelve-month return on equity of 63.32%. What ETFs hold Clever Leaves' stock? ETFs with the largest weight of Clever Leaves (NASDAQ:CLVR) stock in their portfolio include AdvisorShares Pure Cannabis ETF (YOLO).Amplify Seymour Cannabis ETF (CNBS). When did Clever Leaves' stock split? Clever Leaves's stock reverse split on the morning of Friday, August 25th 2023. The 1-30 reverse split was announced on Thursday, August 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Clever Leaves? Shares of CLVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CLVR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe World's First "$20 Trillion Drug?"Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
